170 related articles for article (PubMed ID: 33040400)
1. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
3. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases.
Sahu S; Sharma S; Gupta P; Dey P
Acta Cytol; 2021; 65(3):242-249. PubMed ID: 33827073
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Epithelial Cell Adhesion Molecule Flow Cytometry for Diagnosis of Metastatic Carcinoma in Serous Effusions.
Khodadadi N; Mokhtari M
Acta Cytol; 2023; 67(3):265-272. PubMed ID: 36626892
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA flow cytometry and image cytometry on effusion fluid.
Saha I; Dey P; Vhora H; Nijhawan R
Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
[TBL] [Abstract][Full Text] [Related]
6. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
[TBL] [Abstract][Full Text] [Related]
7. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
8. DNA Ploidy Analysis and Cell Block Immunohistochemistry in the Diagnosis of Malignant Effusions.
Puri M; Sen R; Gupta M; Kalra R; Bhargava S; Puri K
Acta Cytol; 2020; 64(3):256-264. PubMed ID: 31466063
[TBL] [Abstract][Full Text] [Related]
9. Multicoloured flow cytometry to detect metastatic carcinoma in lymph node by epithelial cell adhesion molecule.
Pradhan N; Susheilia S; Gupta P; Kundu R; Rajasekaran S; Dey P
Diagn Cytopathol; 2023 Mar; 51(3):191-195. PubMed ID: 36409514
[TBL] [Abstract][Full Text] [Related]
10. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
Ang PP; Tan GC; Karim N; Wong YP
Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
[TBL] [Abstract][Full Text] [Related]
12. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of flow cytometry in detecting malignant epithelial cells in serous effusions.
Gaur G; Awasthi NP; Gupta A; Agarwal A; Sachan R; Malhotra KP; Shukla S; Singh AK; Singh P; Husain N
J Am Soc Cytopathol; 2023; 12(6):423-435. PubMed ID: 37839931
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
[TBL] [Abstract][Full Text] [Related]
15. Cytology and flow cytometry of malignant effusions of multiple myeloma.
Palmer HE; Wilson CS; Bardales RH
Diagn Cytopathol; 2000 Mar; 22(3):147-51. PubMed ID: 10679993
[TBL] [Abstract][Full Text] [Related]
16. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
Pillai V; Cibas ES; Dorfman DM
Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
[TBL] [Abstract][Full Text] [Related]
17. Additional techniques in serous effusions.
Hanselaar AG
Anal Cell Pathol; 2002; 24(1):1-4. PubMed ID: 12216539
[TBL] [Abstract][Full Text] [Related]
18. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
Gupta S; Sodhani P; Jain S
J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]